Table 2

Clinical features of primary bladder adenocarcinoma
Case No Age Sex Location Size (cm) Procedure Stage¥ Follow-up (months) Outcome Residual disease
1 63 F Posterior 3.6 Cystourethrectomy T4aN2M0 33 AWD£ Lymph node metastasis
2 54 F Posterior & Lateral 4 Radical cystectomy T4bN2M0 16 NED
3 87 M Posterior 6 Partial cystectomy T1N0M0 13 NED
4 53 M Anterior 3.6 Partial cystectomy T3N0M0 4 NED
5 70 M Posterior 6.8 TURBT T4N0M0 2 DOD
6 62 M Posterior 3.5 TURBT T2bN0M1 18 AWD Lung and pleural metastasis
7 59 M Anterior 2.9 Partial cystectomy T3aN0M0 132 NED
8 59 M Anterior 2.9 Partial cystectomy T3aN0M0 128 NED
9 62 M Anterior 4 Radical cystectomy T4N0M0 36 AWD Lung and pleural metastasis
10 80 M Posterior & Anterior 8 Radical cystectomy T3aN1M0 2 AWD Multiple bony metastasis
11 56 M Posterior 5 Radical cystoprostatectomy T3aN2M0 4 NED
12 70 M Multifocal 0.3-0.7 Radical cystoprostatectomy T2aN0M0 2 NED

† − Tumor located predominantly in posterior wall with other tumor nodules in anterior and lateral walls. ‡ − TURBT – Transurethral resection of bladder tumor. ∂ - NED – No evidence of disease. € - DOD – Died of disease. £ - AWD – Alive with disease. ¥ -Pathologic stage.

Roy et al.

Roy et al. Diagnostic Pathology 2012 7:151   doi:10.1186/1746-1596-7-151

Open Data